Catalyst Wire Dossier Catalyst Wire Dossier

WID-RGC20 (Cariprazine)

cariprazine · Whanin Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WID-RGC20 (Cariprazine), covering 2021-12-22 to 2021-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia [Phase 3]

See pricing